Nuvalent appoints Anna Protopapas as independent Board Chair

Nuvalent, Inc.

Anna Protopapas elected as Class I director and Board Chair, effective March 30, 2022.
Protopapas is independent under Nasdaq rules; no committee assignments at this time.
Received initial option grant for 40,000 shares at $14.08 exercise price, vesting over three years.
Compensation per non-employee director policy; also eligible for annual cash retainers and equity grants.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Anna Protopapas

Chairperson of the Board

NUVL · Nuvalent, Inc.

Effective: 2022-03-30
Filed: March 31, 2022, 7:59 PM ET

On March 30, 2022, in accordance with the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors (the “Board”) of Nuvalent, Inc. (the “Company”), the Board elected Anna Protopapas as a member of the Board, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Anna Protopapas was elected as Chairperson of the Board at Nuvalent, Inc..

Action: elected
Role: Chairperson of the Board

Exact text from the filing

On March 30, 2022, in accordance with the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors (the “Board”) of Nuvalent, Inc. (the “Company”), the Board elected Anna Protopapas as a member of the Board, effective immediately.

View on SEC.gov

Nuvalent, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-090644

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.